This article was reviewed by Dr. Charles C. Wykoff, MD, PhD
Cheryl Guttman Krader
The accuracy of IOL power calculations continues to improve with the use of modern instruments for biometry, updated formulas, and constant optimization.
This article was reviewed by Chirag D. Jhaveri, MD
Early identification, aggressive treatment critical; when to consider surgical intervention
Speaking at AAO 2019, Ashraf El Habbak MD, PhD pointed out that bevacizumab inhibits vascular endothelial growth factor, which is a potent permeability factor implicated in cystoid macular edema.
According to William D. Trattler, MD, surgeons today can choose from a number of newer modalities that address the drawbacks associated with previous options.
Speakers at AAO 2019 event describe journey leading to approval of the first gene therapy for a genetic disease.
Tools for higher-order OCT assessment enable evaluation of features of interest, such as targeted retinal layers or fluid compartments, and may allow for unique characterization of disease phenotypes and treatment response.
Study shows routine use may improve patient management, guide procedure planning
A retrospective population-based controlled study analyzing data from an unselected patient population undergoing phacoemulsification surgery found that neither the need for unplanned postoperative visits for complications nor the inciden